NCT07725588

Brief Summary

Approximately 450,000 Veterans Health Administration service users have both posttraumatic stress disorder (PTSD) and chronic pain (CP); treatments that efficiently target both PTSD and CP are limited, and new interventions should address the unique needs of Veterans with PTSD/CP. Mantram Repetition Program (MRP), a meditation-based program, appears well-suited to address these high-priority VA needs. MRP has established effectiveness for treatment of PTSD, is broadly acceptable, can be learned quickly and applied flexibly. However, rigorous testing is needed for pain-related outcomes among a PTSD/CP population. The proposed study will include a randomized controlled trial comparing the efficacy of MRP for PTSD/CP to Health Education while Living with Pain among a sample of 170 Veterans with comorbid PTSD/CP. The primary outcomes will be PTSD symptoms and pain interference. Results from this study will directly inform patient care among the nearly 4% of Veterans with PTSD/CP.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
43mo left

Started Apr 2027

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2027

Expected
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2030

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2030

Last Updated

July 27, 2026

Status Verified

July 1, 2026

Enrollment Period

3 years

First QC Date

July 21, 2026

Last Update Submit

July 24, 2026

Conditions

Keywords

Meditation

Outcome Measures

Primary Outcomes (2)

  • The Revised Clinician-Administered PTSD scale for DSM-5 (CAPS-5-R)

    The CAPS-5-R is a widely-used, well-validated clinician interview that diagnoses PTSD and assesses the severity of PTSD symptoms. Total severity scores range from 0-200, with higher scores indicated greater severity.

    0, 5, 10, 20 weeks

  • Patient Reported Outcome Short Form Pain Interference (PROMIS-PI short form v1.1)

    The PROMIS-PI short form is a self-report measure of pain-related functional interference. PROMIS-PI items are self-rated from 1 to 5; responses range from 1 ("not at all") to 5 ("very much"). The PROMIS-PI is psychometrically sound and provides meaningful estimates of change in pain interference in clinical samples.

    0, 5, 10, 20 weeks

Secondary Outcomes (2)

  • Insomnia Severity Index (ISI)

    0, 5, 10, 20 weeks

  • Pre-Sleep Arousal Scale (PSAS)

    0, 5, 10, 20 weeks

Study Arms (2)

mantram repetition program

EXPERIMENTAL

8-session group-based meditation training class led by a trained instructor

Behavioral: Mantram Repetition Program for PTSD + Pain

health education

ACTIVE COMPARATOR

8-session group-based health education and discussion led by a trained instructor

Behavioral: Health Education while Living with Pain

Interventions

manualized Mantram Repetition Program adapted for Veterans with PTSD and chronic pain

Also known as: MRP
mantram repetition program

manualized health and wellness psychoeducation and discussion group

Also known as: H.E.L.P.
health education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • U.S. Veteran
  • Diagnosis of PTSD
  • Chronic, non-malignant pain:
  • (a) pain most days (\> 3 days/week) for at least 6 months
  • (b) average pain severity and interference with enjoyment of life and/or general
  • Willing/able to engage in study activities

You may not qualify if:

  • Significant current risk of suicide or homicide
  • Untreated severe alcohol or substance use disorder
  • Untreated/unstable serious mental health disorders, such as psychotic disorders, bipolar disorder, or serious dissociative symptoms
  • Impaired mental status
  • Concurrent interventions specifically targeting PTSD or CP or social functioning (e.g., couples therapy) or any meditative or mind-body intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA San Diego Healthcare System, San Diego, CA

San Diego, California, 92161-0002, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticChronic Pain

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Anne L Malaktaris

    VA San Diego Healthcare System, San Diego, CA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anne L Malaktaris

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome evaluator is blind to experimental condition
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental condition: manualized Mantram Repetition Program protocol, an 8-session group-based meditation training class led by a trained instructor Control condition: manualized health education protocol, an 8-session group-based health education and discussion led by a trained instructor
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 24, 2026

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

April 1, 2030

Study Completion (Estimated)

September 30, 2030

Last Updated

July 27, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Specific parameters of sharing are not yet established

Locations